Tasso Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 68
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $17M
Latest Deal Amount
  • Investors
  • 15

Tasso General Information

Description

Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. The company's devices are disposable, small in size, and have an interchangeable cartridge to ensure that the right blood preparation starts as soon as the sample is taken, enabling patients to painlessly administer their own blood samples and mail them back to the lab for analysis in a hassle-free manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Primary Office
  • 1631 15th Avenue West
  • Suite 105
  • Seattle, WA 98119
  • United States
+1 (206) 000-0000

Tasso Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tasso Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 22-Jul-2020 $17M 000.00 0000 Completed Generating Revenue
8. Seed Round 05-Mar-2019 00.00 00.000 000.00 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2017 00000 00000 000 Completed Generating Revenue
6. Grant 01-Jan-2017 00000 00.00 Completed Generating Revenue
5. Grant 01-Jan-2016 00000 00.00 Completed Generating Revenue
4. Grant 01-Jan-2015 00.000 00.00 Completed Generating Revenue
3. Grant 01-Jan-2014 00.000 00.00 Completed Generating Revenue
2. Grant 01-Jan-2013 $546K $1.5K Completed Generating Revenue
1. Capitalization 01-Jan-2012 $1.5K $1.5K Completed Startup
To view Tasso’s complete valuation and funding history, request access »

Tasso Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Tasso’s complete cap table history, request access »

Tasso Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. The company's devices
Diagnostic Equipment
Seattle, WA
68 As of 2021
000.00
000 0000-00-00
00000000000 000.00

0000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000000000 000000000
Gland, Switzerland
0 As of 0000
00.000
0000000000 00.000

0000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000000000 000000000
Medford, MA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tasso Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemaXis Venture Capital-Backed Gland, Switzerland 0 00.000 0000000000 00.000
0000000 000000 Venture Capital-Backed Medford, MA 00 000.00 00000000000 000.00
000000 00000000000 Venture Capital-Backed Pleasanton, CA 0 000000000000
000000 Formerly VC-backed Union City, CA 000 000.00 000000&0 000.00
000000 00000000 Formerly VC-backed San Francisco, CA 00 000.00 000000&0 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Tasso Executive Team (3)

Name Title Board Seat Contact Info
Ben Casavant Ph.D Co-Founder, Chief Executive Officer & Board Member
Erwin Berthier Co-Founder, Chief Technology Officer & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Tasso Board Members (7)

Name Representing Role Since
Alan Levy Ph.D Self Chairman 000 0000
Ben Casavant Ph.D Tasso Co-Founder, Chief Executive Officer & Board Member 000 0000
Betsy Hambrecht Self Board Member 000 0000
Dominique Freeman Tasso Board Member 000 0000
Erwin Berthier Tasso Co-Founder, Chief Technology Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Tasso Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tasso Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Foresite Capital Management Growth/Expansion Minority 000 0000 000000 0
Hambrecht Ducera Growth Ventures Venture Capital Minority 000 0000 000000 0
J2 Ventures Venture Capital Minority 000 0000 000000 0
Merck Global Health Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
Vertical Ventures Real Estate Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »